ZQZhen‐Yu Qi

Zhen‐Yu Qi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhen‐Yu Qi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Anatoly B. Rosenfeld

    Centre for Medical Radiation Physics, University of Wollongong

    2 shared publications
  • Dean Cutajar

    Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW 2522, Australia

    2 shared publications
  • Michael L. F. Lerch

    Centre for Medical Radiation Physics, University of Wollongong

    2 shared publications
  • Shao‐Min Huang

    State Key Laboratory of Oncology in Southern China, and Radiation Oncology Department, Sun Yat‐Sen University Cancer Center, Guangzhou 510060, China

    2 shared publications
  • Xiao‐Wu Deng

    State Key Laboratory of Oncology in Southern China, Guangzhou 510060, China, Radiation Oncology Department, Sun Yat‐Sen University Cancer Center, Guangzhou 510060, China, and Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW 2522, Australia

    2 shared publications
  • Ian Kwan

    Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW 2522, Australia

    1 shared publication

Latest Publications

  • In vivo verification of superficial dose for head and neck treatments using intensity‐modulated techniques

    by Zhen‐Yu Qi, Xiao‐Wu Deng, Shao‐Min Huang, Li Zhang, Zhi‐Chun He, X. Allen Li, Ian Kwan, Michael Lerch, Dean Cutajar, Peter Metcalfe, et al.

    Skin dose is one of the key issues for clinical dosimetry in radiation therapy. Currently planning computer systems are unable to accurately predict dose in the buildup region, leaving ambiguity as to the dose levels actually received by the patient's skin during radiotherapy. This is one of the prime reasons why in vivo measurements are necessary to estimate the dose in the buildup region. A newly developed metal‐oxide‐semiconductor‐field‐effect‐transistor (MOSFET) detector designed specifically for dose measurements in rapidly changing dose gradients was introduced for accurate in vivo skin dosimetry. The feasibility of this detector for skin dose measurements was verified in comparison with plane parallel ionization chamber and radiochromic films. The accuracy of a commercial treatment planning system (TPS) in skin dose calculations for intensity‐modulated radiation therapy treatment of nasopharyngeal carcinoma was evaluated using MOSFET detectors in an anthropomorphic phantom as well as on the patients. Results show that this newly developed MOSFET detector can provide a minimal but highly reproducible intrinsic buildup of corresponding to the requirements of personal surface dose equivalent Hp (0.07). The reproducibility of the MOSFET response, in high sensitivity mode, is found to be better than 2% at the phantom surface for the doses normally delivered to the patients. The MOSFET detector agrees well with the Attix chamber and the EBT Gafchromic® film in terms of surface and buildup region dose measurements, even for oblique incident beams. While the dose difference between MOSFET measurements and TPS calculations is within measurement uncertainty for the depths equal to or greater than , an overestimation of up to 8.5% was found for the surface dose calculations in the anthropomorphic phantom study. In vivo skin dose measurements reveal that the dose difference between the MOSFET results and the TPS calculations was on average , ranging from to . The newly designed MOSFET detector encapsulated into a thin water protective film has a minimal reproducible intrinsic buildup recommended for skin dosimetry. This feature makes it very suitable for routine IMRT QA and accurate in vivo skin dosimetry.


  • Verification of the plan dosimetry for high dose rate brachytherapy using metal–oxide–semiconductor field effect transistor detectors

    by Zhen‐Yu Qi, Xiao‐Wu Deng, Shao‐Min Huang, Jie Lu, Michael Lerch, Dean Cutajar, Anatoly Rosenfeld

    The feasibility of a recently designed metal–oxide–semiconductor field effect transistor (MOSFET) dosimetry system for dose verification of high dose rate (HDR) brachytherapy treatment planning was investigated. MOSFET detectors were calibrated with a NE‐2571 Farmer‐type ionization chamber in water. Key characteristics of the MOSFET detectors, such as the energy dependence, that will affect phantom measurements with HDR sources were measured. The MOSFET detector was then applied to verify the dosimetric accuracy of HDR brachytherapy treatments in a custom‐made water phantom. Three MOSFET detectors were calibrated independently, with the calibration factors ranging from . A distance dependent energy response was observed, significant within from the source. The new MOSFET detector has a good reproducibility , small angular effect , and good dose linearity . It was observed that the MOSFET detectors had a linear response to dose until the threshold voltage reached approximately for source measurements. Further comparison of phantom measurements using MOSFET detectors with dose calculations by a commercial treatment planning system for computed tomography‐based brachytherapy treatment plans showed that the mean relative deviation was for dose points away from the source and for dose points located away. The percentage deviations between the measured doses and the planned doses were below 5% for all the measurements. The MOSFET detector, with its advantages of small physical size and ease of use, is a reliable tool for quality assurance of HDR brachytherapy. The phantom verification method described here is universal and can be applied to other HDR brachytherapy treatments.